EY Health Sciences & Wellness podcast series artwork

EY Health Sciences & Wellness podcast series

24 episodes - English - Latest episode: about 1 year ago - ★★★★★ - 1 rating

The EY Health Sciences and Wellness Experience podcast explores the age of “Health Experience.” All who use and touch the heath care value chain will soon demand a service that provides a more personalized and enhanced outcome. Join us and our guests, as we expand the traditional definitions of innovation to meet ever growing needs and expectations.

Business News News Science businessmodels health healthcare lifesciences medicaltechnology medtech
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

How the path to a sustainable health system unlocks value

March 29, 2023 06:43 - 32 minutes - 59.7 MB

In this episode of the EY Health Sciences and Wellness Experience Podcast, Aloha McBride and her guests explore health inequity, sustainable change and environmental impact of the health industry.   Our panel of experts discuss the evolution of sustainability in health. The explore where organizations can start on their sustainability journey, how they can create sustainable change, and reduce climate impact. Through exploring global examples. they show how data and analytics play a key ...

How global events are shaping the pharmaceutical supply chain

March 26, 2023 22:01 - 23 minutes - 32.8 MB

In today's episode we focus on the EY report on the Pharma supply chains of the future, and discuss the impact of global events and how a new supply chain model can emerge in the pharma industry.   The speakers discuss the future of pharmaceutical supply chains in the wake of the COVID-19 pandemic and other geopolitical events and shifts that are unfolding around us. The discussion covers the impact of global events that have led to a revaluation of globalized supply chain models and a c...

How life sciences companies are measuring their ESG impact

December 19, 2022 16:04 - 26 minutes - 59.6 MB

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact.   Together they review the growing importance of sustainable health solutions, ESG in healthcare and sustainability reporting in the Health Sciences and Wellness industry. Learn how ESG reporting and the information flow that helps businesses successfully engage with their stakeholders.   The conve...

How unlocking the power of data can fuel better health outcomes

May 08, 2022 14:00 - 22 minutes - 20.6 MB

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation and look into innovation in healthcare and health care data science.   They discuss the unique complexities of healthcare – a sector with new entrants, new regulations, consolidation, pricing pressures, and an ageing population that need...

How women are shaping the life sciences industry

March 22, 2022 18:28 - 29 minutes - 17.2 MB

In this episode of the EY Health Sciences and Wellness Experience podcast we focus on women in health. Join Pamela Spence, EY Global Health Sciences and Wellness Leader, as she speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novartis.   Together they discuss their own unique career journeys within the health sciences and wellness industry. They also share with us those c...

Celebrating women in life sciences

March 22, 2022 18:28 - 29 minutes - 17.2 MB

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novartis, as they discuss their own unique career journeys within the health sciences and wellness industry. They also share with us those critical lessons they have learned from their mentors...

How data can help redesign the health experience

February 21, 2022 17:58 - 16 minutes - 15.4 MB

In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, Jackie Hunter, Board Director of Benevolent AI and Ridwaan Jhetam, VP Global Medical for Haematology, BMS, discuss the importance of data science in healthcare and how it can help redesign the health experience and the future of health.   In this wide-ranging discussion, the expert panel approach the topic of health economy and smart health from their d...

How shorter clinical trial processes prolong the lives of people

October 20, 2021 18:20 - 29 minutes - 66.9 MB

There are 2,600 cell and gene therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss what makes an increas...

How shorter clinical trial processes prolong the lives of patients

October 20, 2021 18:20 - 29 minutes - 66.9 MB

There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancements in cell and gene therapy.   In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY...

How digital solutions will help close the health equity gap

August 12, 2021 15:01 - 32 minutes - 45 MB

In the first EY Pointellisä Podcast, Adlai Golderg, Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer, explore and frame the health equity challenges the world is facing today. Addressing health care inequality is a global challenge. For Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer, finding opportunities to provide health equity is a shared passion. Both are experienced physicians, and in this podc...

How digital solutions will help close the health equity gap

August 12, 2021 15:01 - 32 minutes - 45 MB

In this episode, we delve into the global challenge of addressing health inequality with Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer. As experienced physicians, they share their passion for finding opportunities to provide health equity and discuss the root causes of disparities and how unbiased digital medicine can help.   We learn that health care disparity starts much earlier than diagnosis and treatment, with low minority enrolment ra...

The promise of advanced therapies: the patient experience

August 12, 2021 14:59 - 17 minutes - 39.5 MB

In this episode of Pointellis, Adlai Goldberg explores the life-changing world of cancer diagnosis and the path to full remission with Asaf Adler, Operations Senior Manager with EY. Asaf Adler, EY Americas Senior Manager for Consulting, Business Consulting, Supply Chain & Operations, faced among the hardest patient challenges imaginable: stage 4 melanoma and lung cancer. But, today, as a cancer survivor, he’s optimistic about the state of cancer treatments. In this podcast, Adlai Goldberg,...

The promise of advanced therapies: the patient experience

August 12, 2021 14:59 - 17 minutes - 39.5 MB

In this first Pointellis episode, Adlai Goldberg speaks with Asaf Adler, Operations Senior Manager with EY, about his emotional journey from stage 4 melanoma to full remission. Asaf Adler, EY Americas Senior Manager for Consulting, Business Consulting, Supply Chain & Operations, faced among the hardest patient challenges imaginable: stage 4 melanoma and lung cancer. But, today, as a cancer survivor, he’s optimistic about the state of cancer treatments. In this podcast, Adlai Goldberg, EY S...

The Age of Health Experience

August 12, 2021 14:57 - 8 minutes - 18.3 MB

In this first episode of our EY Health Sciences and Wellness Experience podcast series, we explore the emerging and much needed age of “Health Experience” and the disruptive health innovation emerging in the aftermath of the covid 19 pandemic.   The Covid 19 impact on healthcare was immense and Health Sciences and Wellness industry has never been as “front and centre” in our lives as it has been in this last year. As all of us, worldwide, ride the various waves of the pandemic, our Healt...

Five trends driving the emergence of personalized Health ecosystem

June 01, 2020 15:53 - 28 minutes - 38.5 MB

The COVID-19 pandemic provides the ‘burning platform’ for accelerating the data agenda. New data-based tools and technologies make a more personalized approach to health and wellness possible. The world has never needed this more than now. While companies and organizations long recognized the potential of new tools to capture and use data to transform health, they lacked the “burning platform” to fuel this change. The COVID-19 pandemic and the global disruption it caused has demonstrated tha...

New Horizons: What connections will move health from reimagining to reality?

April 17, 2020 09:11 - 26 minutes - 36.6 MB

New technologies are creating new opportunities, but they are also creating unknown and unquantified risks. Organizations that understand what it takes to succeed with new cost and revenue models, new value propositions, and new relationships with the right partners, will start to reshape the health market. In this edition of New Horizons, we explore four areas where this process of reshaping is underway.

Firepower 2020

February 19, 2020 16:17 - 20 minutes - 37.1 MB

With dealmaking a cornerstone of the growth strategy, 2020 will be a robust year for life sciences M&A. To succeed, companies must continue to focus their business models, close near term growth gaps and invest in future innovation.

Pulse of the industry 2019

November 05, 2019 17:00 - 26 minutes - 24 MB

In the EY 2019 Pulse of the industry, we review the performance of the global medical technology industry. The industry continues to grow, but its long-term outlook is at risk from underinvestment in R&D and lack of collaboration between industry providers, payers and patients.

How can we make common ground the foundation for real change?

October 10, 2019 07:45 - 30 minutes - 70.3 MB

Nothing can change if minds do not. How can we make common ground the foundation for real change? As technology increasingly takes on the role of management, more emphasis falls on the role of leaders. Neuroscience is uncovering approaches to influence that leaders can use to enlist others to share their beliefs and commitments.   In this episode of The Better Question, EYQ Fellow Chris Meyer is joined by Tali Sharot, professor of cognitive neuroscience at University College London and E...

Unlocking the power of data to improve health outcomes: five trends to watch (Audiobook)

May 09, 2019 08:21 - 24 minutes - 45.4 MB

Data is the driving force underpinning the Fourth Industrial Revolution and the emergence of new business models. In health care, the goal is to use data to deliver interventions more proactively and in more personalized ways, ultimately leading to better health outcomes and a shift to prevention. Five trends are leading the rise of a new, data-centric approach to health care. An organization’s ability to generate value depends on how effectively it can unlock the power of data and generat...

2019 EY M&A Firepower report (Audiobook)

February 06, 2019 12:56 - 21 minutes - 19.5 MB

Over the past three decades, life sciences companies have used their biological and chemical know-how to create significant value for themselves, their shareholders and most importantly patients. In today’s fast-changing environment, it’s very likely that life sciences companies will need access to an array of medical and non-medical data to demonstrate value to their stakeholders. In the latest 2019 EY M&A Firepower report, we explore the dealmaking strategies life sciences should prioritiz...

When a human body is the biggest data platform, who will capture value? (Podcast: Pamela Spence/Jackie Hunter)

January 16, 2019 17:18 - 19 minutes - 43.9 MB

An EY study shows that data and digital are transforming the life sciences industry. Hear from leaders how industry players can seize the upside of this disruption, and what it means for patient-consumers.

EY Pulse of the Industry 2018 (Audiobook)

October 22, 2018 09:47 - 24 minutes - 56 MB

In EY Pulse of the industry, we examine the annual performance of the medical device industry in the context of the technological advances and rising customer expectations associated with the Fourth Industrial Revolution. To thrive in this transformative age, medtechs must adapt their business models to meet the increased expectations of consumers and other health stakeholders. Read more by visiting www.ey.com/pulse Additional audiobook formats include iTunes | Google Play Music | ​Spotify

EY Life Sciences 4.0 (Audiobook)

July 15, 2018 21:03 - 26 minutes - 36.3 MB

In Life Sciences 4.0: securing value through data-driven platforms, we explore how health is being reimagined because of scientific and technological change and rising customer expectations. We also examine the ramifications for life sciences companies' market offerings, business models and the new capabilities needed as the disciplines of health care and technology merge to become "health technology". Read more by visiting us at ey.com/lifesciences  Additional audiobook formats include ...